logo
ONCO logo

Oncopeptides Community

OM:ONCO Community
  • 2 Narratives written by author
  • 1 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

ONCO logo
Oncopeptides
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts

Agreements In Europe And Japan Will Unlock Global Markets

Key Takeaways Strategic agreements in Europe and potential licensing in Japan will unlock major markets, enhancing future earnings and revenue growth. Cost management alongside sales expansion in core European markets aims to achieve cash flow positivity, positively impacting net margins by 2026.
View narrative
SEK 2.50
FV
41.0% undervalued intrinsic discount
120.02%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 9 hours ago author updated this narrative
ONCO logo
Oncopeptides
DA
DailyInvestors
Community Contributor

Oncolytics Biotech: A Beacon of Hope in Cancer Treatment

Oncolytics Biotech: A Beacon of Hope in Cancer Treatment In the ever-evolving landscape of oncology, Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) is emerging as a company demonstrating significant promise.
View narrative
SEK 2.56
FV
42.3% undervalued intrinsic discount
47.64%
Revenue growth p.a.
0users have liked this narrative
1users have commented on this narrative
4users have followed this narrative
4 months ago author updated this narrative